Institut de recherche biomédicale
     
    Vous êtes ici : Accueil / La Recherche / Endocrinologie, Métabolisme, Diabète. / Equipe C. Postic, T. Issad / Signalisation Insuline/IGF1 et O-GLcNAc glycosylation / Le récepteur de l'IGF1 et les hybrides IR/IGF1R (Groupe Tarik Issad)

    Publications de l'équipe : Signalisation de l'insuline et du glucose, et glucotoxicité

    154 publication(s) trouvée(s)

    • Ramos-Martinez, I., Martinez-Loustalot, P., Lozano, L., Issad, T., Limon, D., Diaz, A., Perez-Torres, A., Guevara, J., Zenteno, E. Neuroinflammation induced by amyloid beta25-35 modifies mucin-type O-glycosylation in the rat's hippocampus Neuropeptides 2018; 67:56-62
    • Pique, C., Issad, T. [Sweet hijacking by the Tax oncoprotein of the Human T-cell lymphotropic virus type 1] Med Sci (Paris) 2018; 34(2):120-122
    • Benhamed, F., Postic, C. A new pathway to eSCAPe lipotoxicity Clin Res Hepatol Gastroenterol 2018; 42(1):3-5
    • Richards, P., Rachdi, L., Oshima, M., Marchetti, P., Bugliani, M., Armanet, M., Postic, C., Guilmeau, S., Scharfmann, R. MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic beta-Cells Diabetes 2018; 67(3):461-472
    • Bricambert, J., Alves-Guerra, M. C., Esteves, P., Prip-Buus, C., Bertrand-Michel, J., Guillou, H., Chang, C. J., Vander Wal, M. N., Canonne-Hergaux, F., Mathurin, P., Raverdy, V., Pattou, F., Girard, J., Postic, C., Dentin, R. The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity Nat Commun 2018; 9(1):2092
    • Regnier, M., Polizzi, A., Lippi, Y., Fouche, E., Michel, G., Lukowicz, C., Smati, S., Marrot, A., Lasserre, F., Naylies, C., Batut, A., Viars, F., Bertrand-Michel, J., Postic, C., Loiseau, N., Wahli, W., Guillou, H., Montagner, A. Insights into the role of hepatocyte PPARalpha activity in response to fasting Mol Cell Endocrinol 2018; 471:75-88
    • Fougerat, A., Pan, X., Smutova, V., Heveker, N., Cairo, C. W., Issad, T., Larrivee, B., Medin, J. A., Pshezhetsky, A. V. Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice Mol Metab 2018; 12:76-88
    • Abderrahmani, A., Yengo, L., Caiazzo, R., Canouil, M., Cauchi, S., Raverdy, V., Plaisance, V., Pawlowski, V., Lobbens, S., Maillet, J., Rolland, L., Boutry, R., Queniat, G., Kwapich, M., Tenenbaum, M., Bricambert, J., Saussenthaler, S., Anthony, E., Jha, P., Derop, J., Sand, O., Rabearivelo, I., Leloire, A., Pigeyre, M., Daujat-Chavanieu, M., Gerbal-Chaloin, S., Dayeh, T., Lassailly, G., Mathurin, P., Staels, B., Auwerx, J., Schurmann, A., Postic, C., Schafmayer, C., Hampe, J., Bonnefond, A., Pattou, F., Froguel, P. Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes Diabetes 2018; 67(7):1310-1321
    • Hoyles, L., Fernandez-Real, J. M., Federici, M., Serino, M., Abbott, J., Charpentier, J., Heymes, C., Luque, J. L., Anthony, E., Barton, R. H., Chilloux, J., Myridakis, A., Martinez-Gili, L., Moreno-Navarrete, J. M., Benhamed, F., Azalbert, V., Blasco-Baque, V., Puig, J., Xifra, G., Ricart, W., Tomlinson, C., Woodbridge, M., Cardellini, M., Davato, F., Cardolini, I., Porzio, O., Gentileschi, P., Lopez, F., Foufelle, F., Butcher, S. A., Holmes, E., Nicholson, J. K., Postic, C., Burcelin, R., Dumas, M. E. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women Nat Med 2018; 24(7):1070-1080
    • Halimi, S., Girard, J. Traitement du diabète de type 2. Où en sommes-nous des voies agissant sur le glucagon ?-Type 2 diabetes treatment. Where are we by acting on glucagon? Medecine des Maladies Metaboliques 2018; 12(1):12-21
    • Halimi, S., Girard, J. Traitement du diabÚte de type 2. Où en sommes-nous des voies agissant sur le glucagon ?-Type 2 diabetes treatment. Where are we by acting on glucagon? Medecine des Maladies Metaboliques 2018; 12(1):16-21
    • Javary, J., Allain-Courtois, N., Saucisse, N., Costet, P., Heraud, C., Benhamed, F., Pierre, R., Bure, C., Pallares-Lupon, N., Do Cruzeiro, M., Postic, C., Cota, D., Dubus, P., Rosenbaum, J., Benhamouche-Trouillet, S. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling Gut 2018; 67(12):2192-2203
    • Richards, P., Ourabah, S., Montagne, J., Burnol, A.-F., Postic, C., Guilmeau, S. MondoA/ChREBP: The usual suspects of transcriptional glucose sensing; Implication in pathophysiology Metabolism - Clinical and Experimental 2017; 70:133-51
    • Morzyglod, L., Cauzac, M., Popineau, L., Denechaud, P. D., Fajas, L., Ragazzon, B., Fauveau, V., Planchais, J., Vasseur-Cognet, M., Fartoux, L., Scatton, O., Rosmorduc, O., Guilmeau, S., Postic, C., Desdouets, C., Desbois-Mouthon, C., Burnol, A. F. Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma Hepatology 2017; 65(4):1352-1368
    • Girard, J. [Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment] Nephrol Ther 2017; 13 Suppl 1:S35-S41
    • Ducheix, S., Montagner, A., Polizzi, A., Lasserre, F., Regnier, M., Marmugi, A., Benhamed, F., Bertrand-Michel, J., Mselli-Lakhal, L., Loiseau, N., Martin, P. G., Lobaccaro, J. M., Ferrier, L., Postic, C., Guillou, H. Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling PLoS One 2017; 12(7):e0181393
    • Groussaud, D., Khair, M., Tollenaere, A. I., Waast, L., Kuo, M. S., Mangeney, M., Martella, C., Fardini, Y., Coste, S., Souidi, M., Benit, L., Pique, C., Issad, T. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription PLoS Pathog 2017; 13(7):e1006518
    • Abdul-Wahed, A., Guilmeau, S., Postic, C. Sweet Sixteenth for ChREBP: Established Roles and Future Goals Cell Metab 2017; 26(2):324-341
    • Marciniak, E., Leboucher, A., Caron, E., Ahmed, T., Tailleux, A., Dumont, J., Issad, T., Gerhardt, E., Pagesy, P., Vileno, M., Bournonville, C., Hamdane, M., Bantubungi, K., Lancel, S., Demeyer, D., Eddarkaoui, S., Vallez, E., Vieau, D., Humez, S., Faivre, E., Grenier-Boley, B., Outeiro, T. F., Staels, B., Amouyel, P., Balschun, D., Buee, L., Blum, D. Tau deletion promotes brain insulin resistance J Exp Med 2017; 214(8):2257-2269
    • Iroz, A., Montagner, A., Benhamed, F., Levavasseur, F., Polizzi, A., Anthony, E., Regnier, M., Fouche, E., Lukowicz, C., Cauzac, M., Tournier, E., Do-Cruzeiro, M., Daujat-Chavanieu, M., Gerbal-Chalouin, S., Fauveau, V., Marmier, S., Burnol, A. F., Guilmeau, S., Lippi, Y., Girard, J., Wahli, W., Dentin, R., Guillou, H., Postic, C. A Specific ChREBP and PPARalpha Cross-Talk Is Required for the Glucose-Mediated FGF21 Response Cell Rep 2017; 21(2):403-416